Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Adamina Vocero-Akbani"'
Publikováno v:
Science. 285:1569-1572
Delivery of therapeutic proteins into tissues and across the blood-brain barrier is severely limited by the size and biochemical properties of the proteins. Here it is shown that intraperitoneal injection of the 120-kilodalton β-galactosidase protei
Autor:
Michelle Becker-Hapak, Sergei A. Ezhevsky, Adamina Vocero-Akbani, Dawn G. Latham, Steven F. Dowdy, Eric L. Snyder, Hikaru Nagahara, Alan L. Ho, Natalie A. Lissy
Publikováno v:
Nature Medicine. 4:1449-1452
Transduction of full-length TAT fusion proteins into mammalian cells: TAT-p27 Kip1 induces cell migration
Publisher Summary This chapter describes the methodology to generate and transduce full-length Tat fusion proteins that can be applied to a broad spectrum of proteins independent of size or function. Bacterially expressed N'-terminal in-frame Tat fus
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1e8c09713935f90b46740d089533d50a
https://doi.org/10.1016/s0076-6879(01)32190-0
https://doi.org/10.1016/s0076-6879(01)32190-0
Currently, delivery of expression vectors, proteins, and/or pharmacologically important peptidyl mimetics to target cells is problematic because of the low percentage of cells targeted, overexpression, size constraints, and bioavailability. Concentra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c4498050000f19ebfe8c7de16aaa263d
https://doi.org/10.1016/s0076-6879(00)22046-6
https://doi.org/10.1016/s0076-6879(00)22046-6
Autor:
Steven F. Dowdy, Hikaru Nagahara, Sergei A. Ezhevsky, Adamina Vocero-Akbani, Philipp Kaldis, Mark J. Solomon
Transforming growth factor β (TGF-β)-mediated G 1 arrest previously has been shown to specifically target inactivation of cyclin D:cyclin-dependent kinase (Cdk) 4/6 complexes. We report here that TGF-β-treated human HepG2 hepatocellular carcinoma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e5fc29ec1a29113e813c53ab296fabb
https://europepmc.org/articles/PMC24755/
https://europepmc.org/articles/PMC24755/